Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →Astral reported a strong year with piping volume growth of ~23% and adhesive India revenue of INR 960 crore at 15.7% EBITDA margin.
✓ Verified against BSE filing
Astral reported a strong year with piping volume growth of ~23% and adhesive India revenue of INR 960 crore at 15.7% EBITDA margin. The company is expanding capacity with two new pipe plants (Hyderabad, Kanpur) and entering OPVC pipes with proprietary low-CapEx technology. Paints and Bathware are scaling: paints targeting INR 300+ crore in FY25 with 14-15% EBITDA, Bathware aiming for INR 125-150 crore and breakeven. Key risks include polymer price volatility and execution in new verticals. Management guides 15-20% volume growth for pipes and 20%+ for India adhesives, with potential upside from polymer price recovery and market share gains.
एस्ट्रल का साल बहुत अच्छा रहा। पाइपों की बिक्री (वॉल्यूम) लगभग 23% बढ़ी। चिपकने वाले पदार्थों (एडहेसिव) से भारत में 960 करोड़ रुपये की कमाई हुई, जिसमें 15.7% का मुनाफा (EBITDA मार्जिन) रहा। कंपनी दो नए पाइप कारखाने (हैदराबाद, कानपुर) लगा रही है और एक नई तकनीक से OPVC पाइप बनाएगी, जिसमें कम पैसे लगते हैं। पेंट और बाथरूम का सामान (बाथवेयर) भी बढ़ रहा है। पेंट से अगले साल 300 करोड़ से ज़्यादा की कमाई और 14-15% मुनाफा होने की उम्मीद है। बाथवेयर 125-150 करोड़ तक पहुंचकर घाटा खत्म करेगा। मुख्य जोखिम हैं: प्लास्टिक के दाम में उतार-चढ़ाव और नए कामों को अंजाम देना। कंपनी को पाइपों की बिक्री में 15-20% और चिपकने वाले पदार्थों में 20% से ज़्यादा बढ़ोतरी की उम्मीद है।
0 delivered, 0 close, 3 missed.
View Promises →Polymer price volatility impacting margins
View Risks →Full transcript text is available on this route.
Read Transcript →Volume growth outpaced value growth of ~9% due to polymer price decline.
India adhesive revenue with 15.7% EBITDA margin; UK business dragged consolidated margins.
Bathware crossed INR 20 Cr in Q4; FY25 target INR 125-150 Cr with breakeven.
Revenue declined due to restructuring; FY25 target INR 300+ Cr with 14-15% EBITDA.
Management guides 15-20% volume growth for pipes, with potential upward revision after H1 based on polymer price and demand trends.
Paints business targets INR 300+ crore revenue in FY25 with EBITDA margin of 14-15%, leveraging Astral brand and distribution.
Bathware business aims to achieve revenue of INR 125-150 crore and turn EBITDA positive in FY25.
Planned CapEx of INR 250 crore for pipes (Hyderabad and Kanpur plants) and INR 50 crore for other businesses, with potential increase if demand is robust.
Management revised guidance to 20%+ volume growth for the full year; 9M already at 24%.
Guidance maintained; 9M margin at 17%+ and Q4 expected to be robust, potentially exceeding guidance.
9M margin at 16%, already surpassing guidance; full year expected to be at or above the range.
Paints and Bathware are still in early stages; achieving revenue and margin targets depends on successful brand building and distribution ramp-up.
Entry of a major cement player and price cuts by incumbents could pressure Astral's paint margins and market share.
Astral brand paint launch in Q1 FY25 may face higher marketing costs and competitive intensity, impacting margins.
Red Sea tensions and Middle East conflicts could disrupt raw material supply and increase costs.
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Primarily for pipe capacity expansion; other divisions' CapEx largely completed.
Mentioned in Q1 FY24, Q2 FY24, Q3 FY24
Management revised guidance to 20%+ volume growth for the full year; 9M already at 24%.
Mentioned in Q1 FY24, Q3 FY24
Astral brand paint launch in Q1 FY25 may face higher marketing costs and competitive intensity, impacting margins.
Mentioned in Q1 FY24, Q3 FY24
Guidance maintained; 9M margin at 17%+ and Q4 expected to be robust, potentially exceeding guidance.
Management guides 15-20% volume growth for pipes, with potential upward revision after H1 based on polymer price and demand trends.
Sharp polymer price increases (10% in Q1) could compress margins if not passed through, though management sees it as positive for organized players.
View Risks →